AminahJatoiMD

Clinical Trials

• Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or Stomach Start of enrollment: 2000 Jan 01

  Completed

  Phase 2

• Carboplatin and Paclitaxel in Treating Older Patients With Metastatic or Recurrent Unresectable Non-small Cell Lung Cancer Start of enrollment: 2000 Jan 01

  Completed

  Phase 2

• Green Tea Extract in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy Start of enrollment: 2000 Dec 01

  Completed

  Phase 2

• Donepezil and Vitamin E to Prevent Side Effects Caused By Radiation Therapy to the Head in Patients Receiving Treatment for Small Cell Lung Cancer Start of enrollment: 2001 Feb 01

  Completed

  Phase 3

• Ceramide Cream in Treating Women With Cutaneous Breast Cancer Start of enrollment: 2001 Jan 01

  Completed

  Phase 2

• Vinorelbine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer Start of enrollment: 2001 Apr 01

  Completed

  Phase 2

• Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction Start of enrollment: 2002 Jan 01

  Completed

  Phase 2

• Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite Start of enrollment: 2000 Mar 01

  Completed

  Phase 3

• Zinc Sulfate in Preventing Loss of Sense of Taste in Patients Undergoing Radiation Therapy for Head and Neck Cancer Start of enrollment: 2002 May 01

  Completed

  Phase 3

• Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer Start of enrollment: 2002 Sep 01

  Completed

  Phase 2

• Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05) Start of enrollment: 2002 Oct 01

  Completed

  Phase 3

• Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With Advanced Cancer Start of enrollment: 2003 May 01

  Completed

  Phase 3

• Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junction Start of enrollment: 2003 Sep 01

  Completed

  Phase 2

• Gefitinib With or Without Carboplatin and Paclitaxel in Treating Older Patients With Unresectable or Metastatic Non-Small Cell Lung Cancer Start of enrollment: 2004 Oct 01

  Completed

  Phase 2

• Lycopene in Treating Patients With Metastatic Prostate Cancer Start of enrollment: 2004 Jan 01

  Completed

  Phase 2

• Creatine in Treating Patients With Cancer-Associated Weight Loss Start of enrollment: 2004 Dec 01

  Completed

  Phase 3

• Tetracycline in Preventing Skin Rash in Patients Who Are Receiving Drugs Such as Gefitinib and Cetuximab for Cancer Start of enrollment: 2004 Dec 01

  Completed

  Not Applicable

• Gefitinib in Treating Patients With Locally Advanced Esophageal Cancer Start of enrollment: 2005 Jul 01

  Completed

  Phase 2

• Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Unresectable, Metastatic Cancer of the Esophagus or Gastroesophageal Junction Start of enrollment: 2005 Aug 01

  Completed

  Phase 2

• Cetuximab and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer Start of enrollment: 2006 Jan 01

  Completed

  Phase 2

• Octreotide in Treating Patients With Cancer-Related Malignant Ascites Start of enrollment: 2005 Oct 01

  Completed

  Phase 3

• Radiation Therapy, Pemetrexed Disodium, and Carboplatin in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery Start of enrollment: 2006 Apr 01

  Terminated

  Phase 2

• Topical Sunscreen in Preventing Skin Rash in Patients Receiving Drugs Such as Erlotinib or Cetuximab for Cancer Start of enrollment: 2006 Oct 01

  Completed

  Phase 3

• Nicotine in Treating "Hunger Pain" in Patients With Malignant Bowel Obstruction Caused By Cancer Start of enrollment: 2003 Dec 01

  Withdrawn

  Not Applicable

• Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer Start of enrollment: 2007 May 01

  Completed

  Phase 2

• Capecitabine With or Without Sunitinib Malate as First-Line Therapy in Treating Patients With Metastatic Cancer of the Esophagus or Gastroesophageal Junction Start of enrollment: 2009 Aug 01

  Completed

  Phase 2

• White Wine or Nutritional Supplement in Improving Appetite in Patients With Cancer Start of enrollment: 2009 Jul 01

  Completed

  Not Applicable

• Menadione Topical Lotion in Treating Skin Discomfort and Psychological Distress in Patients With Cancer Receiving Panitumumab, Erlotinib Hydrochloride, or Cetuximab Start of enrollment: 2012 Jan 23

  Active, not recruiting

  Not Applicable

• A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer Start of enrollment: 2013 Mar 31

  Terminated

  Phase 3

• Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab Start of enrollment: 2012 Aug 31

  Completed

  Phase 2

• Serum Bovine Immunoglobulin Protein Isolate in Improving Quality of Life and Post-Operative Recovery in Patients With Gynecological Cancer After Undergoing Surgery Start of enrollment: 2013 Oct 04

  Active, not recruiting

  Phase 2

• Auranofin in Decreasing Pain in Patients With Paclitaxel-Induced Pain Syndrome Start of enrollment: 2014 Feb 19

  Completed

  Phase 2

• Disulfiram and Chemotherapy in Treating Patients With Refractory Solid Tumors or Metastatic Pancreatic Cancer Start of enrollment: 2016 Feb 25

  Active, not recruiting

  Phase 1

• Fat Emulsion in Preventing Hypersensitivity Reactions in Patients With Cancer Receiving Carboplatin or Oxaliplatin Start of enrollment: 2017 Jul 14

  Active, not recruiting

  Not Applicable

• Auranofin and Sirolimus in Treating Participants With Ovarian Cancer Start of enrollment: 2018 Mar 30

  Active, not recruiting

  Phase 2

• Maintain Respiratory Muscle Function and Reduce Pneumonia Risk in Cancer Patients Start of enrollment: 2018 May 25

  Completed

  Phase 4

• Ketoconazole in Treating Participants With Ongoing EGFR Inhibitor-Induced Rash Start of enrollment: 2018 Aug 22

  Active, not recruiting

  Early Phase 1

• "Prescribing" Exercise to Cancer Patients at High-Risk for Falls Start of enrollment: 2020 Sep 03

  Recruiting

  Phase 1

• Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer Start of enrollment: 2020 Nov 16

  Active, not recruiting

  Phase 2

• Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients Start of enrollment: 2022 Jan 03

  Recruiting

  Phase 3

  Roles: Contact, Study Chair

• Join now to see all